Search

Your search keyword '"Chilengi, Roma"' showing total 634 results

Search Constraints

Start Over You searched for: Author "Chilengi, Roma" Remove constraint Author: "Chilengi, Roma"
634 results on '"Chilengi, Roma"'

Search Results

4. Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

5. Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study

8. High Asymptomatic Carriage With the Omicron Variant in South Africa

9. Comparative analysis of cholera serum vibriocidal antibodies from Convalescent and vaccinated adults in Zambia

10. The Lancet Commission on water, sanitation and hygiene, and health

12. Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial

13. Spatiotemporal variation in risk of Shigella infection in childhood: a global risk mapping and prediction model using individual participant data

15. Detection and Characterisation of SARS-CoV-2 in Eastern Province of Zambia; A Retrospective Genomic Surveillance Study

16. Detection of Human Adenovirus and Rotavirus in Wastewater in Lusaka, Zambia: Demonstrating the Utility of Environmental Surveillance for the Community

17. A Situation Analysis of the Capacity of Laboratories in Zambia to Conduct Surveillance of Antimicrobial Resistance: Strengths, Weaknesses, Opportunities, and Challenges

18. Single-test syphilis serology: A case of not seeing the forest for the trees

20. Assessment of Antimicrobial Resistance Laboratory-based Surveillance Capacity of Hospitals in Zambia: Findings and Implications for System Strengthening

21. Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review

22. A Situation Analysis of the Capacity of Laboratories in Faith-Based Hospitals in Zambia to Conduct Surveillance of Antimicrobial Resistance: Opportunities to Improve Diagnostic Stewardship.

23. Human cytomegalovirus seropositivity and its influence on oral rotavirus vaccine immunogenicity: a specific concern for HIV-exposed-uninfected infants.

24. Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report

25. NewVibrio choleraesequences from Eastern and Southern Africa alter our understanding of regional cholera transmission

26. The Incidence and Risk Factors for Enterotoxigenic E. coli Diarrheal Disease in Children under Three Years Old in Lusaka, Zambia

27. COVID-19 mortality sentinel surveillance at a tertiary referral hospital in Lusaka, Zambia, 2020–2021

28. Antibiotic prescribing patterns and carriage of antibiotic-resistant Escherichia coli and Enterococcus species in healthy individuals from selected communities in Lusaka and Ndola districts, Zambia

29. Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic Escherichia coli among Children in Zambia Participating in a Phase I Clinical Trial

30. Metabolic syndrome among treatment‐naïve people living with and without HIV in Zambia and Zimbabwe: a cross‐sectional analysis

31. Three transmission events of Vibrio cholerae O1 into Lusaka, Zambia

35. Test negative case–control study of COVID-19 vaccine effectiveness for symptomatic SARS-CoV-2 infection among healthcare workers: Zambia, 2021–2022

36. Characterization of Rotavirus Strains Responsible for Breakthrough Diarrheal Diseases among Zambian Children Using Whole Genome Sequencing

37. Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0–36 Months in Peri-Urban Areas of Lusaka

38. Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach

41. Ecological Niche Modeling of Aedes and Culex Mosquitoes: A Risk Map for Chikungunya and West Nile Viruses in Zambia

43. Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (RotarixTM) Immunogenicity among Infants in Zambia

44. Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia

45. Maternal and Infant Histo-Blood Group Antigens (Hbga) Profiles and It’s Influence on Oral Rotavirus Vaccine (Rotarix®) Immunogenicity Among Infants in Zambia

49. A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children

Catalog

Books, media, physical & digital resources